Assessing the efficacy of celecoxib after tonsillectomy and/or adenoidectomy: A systematic review and meta‐analysis of randomised control trials

Umm E Salma Shabbar Banatwala,Abdul Rehman Shah Syed,Noor Ul Ain,Aimen Zulfikar,Ilqa Ikram Akhund,Rija Lodhi,Rameesha Baig,Laiba Ghufran,Ayesha Rizwan,Meena Bai,Mahima Khatri,Satesh Kumar
DOI: https://doi.org/10.1111/coa.14177
IF: 2.729
2024-06-16
Clinical Otolaryngology
Abstract:Objectives Tonsillectomy and adenoidectomy are common surgical procedures that cause persistent pain, bleeding, and functional limitations. We aimed to investigate the efficacy of celecoxib compared with a placebo for managing post‐tonsillectomy or adenoidectomy pain and other adverse events. Design Systematic review and meta‐analysis. Methods We conducted a systematic literature search in the PubMed, Cochrane, and Google Scholar databases from inception until July 2023. Dichotomous outcomes have been reported as risk ratios (RR) while continuous outcomes were reported using mean differences (MD). A funnel plot was drawn to investigate publication bias. Results From 1394 records identified, 6 randomised double‐blind trials comprising 591 participants undergoing tonsillectomy and/or adenoidectomy were eligible for inclusion. A high dose (400 mg) of celecoxib was effective in decreasing the pain score for 'worst pain' after the procedure (MD: −10.98, [95% CI: −11.53, −10.42], p
otorhinolaryngology
What problem does this paper attempt to address?